Qiagen and National Cancer Institute, Qiagen and Artus, Fisher Scientific, Exiqon, and Bio-Rad Laboratories | GenomeWeb

Qiagen to Work with NCI on siRNA Development …

Qiagen said this week that it has struck a deal with the National Cancer Institute to develop a validated set of siRNAs for use by NCI researchers.

According to the company, the siRNAs will be made available to the general research community after characterization work is complete.

Additional terms of the arrangement were not disclosed.

… And Announces Acqusition of Diagnostics Firm Artus

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.